BridgeMD
Tests treatment safety and results for Smoking Cessation; Tobacco Dependence
Official title the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation
ClinicalTrials.gov ID: NCT06762210
What this study is testing
- What it's testing
- Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 65
You may be able to join if
- Adults aged 18-65 years
- smoke ≥5 cigarettes per day
- motivated to quit smoking,
- have access to a smartphone or computer
You likely can't join if
- Pregnant women
- individuals with severe psychiatric conditions
- those already using other smoking cessation therapies.
The study team makes the final eligibility decision.
Where it's taking place
- Fayoum, Alexandria Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fayoum, Alexandria Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.